Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 New Skin Microbiome Technology for L'Oréal - Happi

What are you searching for?

Sign in
Company News

New Skin Microbiome Technology for L’Oréal

Accord with Micreos will give L'Oréal access to biotech company's active protein endolysin.

Author Image

By: Christine Esposito

Editor-in-Chief, Happi / Rodman Media

L'Oréal and Micreos, which develops new biological therapies based on phage and endolysin technology, have signed a license agreement to join their expertise in biotechnology and the skin microbiome.

Under the terms of the agreement, Micreos will give L'Oréal access to its endolysin, a type of active protein in the cosmetic field. With this technology, it is possible for the first time to target only unwanted bacteria in the skin flora, according to Micreos.
 
For 15 years, L'Oréal's Research & Innovation has been cooperating with scientific institutions and conducting clinical studies to better understand the role of the skin microbiome. “The agreement with Micreos opens up a very promising field in high-tech cosmetics,” Laurent Attal, executive vice-president research and innovation of L'Oréal, said in a statement.
 
“We expect this partnership to be ground-breaking. L'Oréal has been a leader in skincare for decades. Micreos is at the forefront of targeted bacterial biotechnology. We pair our strengths and millions stand to benefit,” noted Micreos CEO Mark Offerhaus.
 
Micreos' pharma development program includes endolysins that all target Staphylococcus bacteria, which cause or aggravate a broad range of health issues, including skin condition.
 
You can learn more about new developments in the skin microbiome in Happi’s November 2020 issue, due out online next week.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Add Happi as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Happi Newsletters

Topics